Trials / Completed
CompletedNCT03386136
Therapeutic Oxygen for Gastrointestinal Atony (TOGA)
Therapeutic Oxygen for Gastrointestinal Atony (TOGA): Pilot Trial - Management of Acute Colonic Pseudo-Obstruction With Oxygen Supplementation
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- University of Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
This study is a non invasive study to see if 100% oxygen therapy will help to resolve an intestinal obstruction.
Detailed description
TOGA involves the provision of a 6- hour treatment with 100% oxygen via non breather mask to hospitalized patients with ileus, small bowel obstruction and/or colonic pseudo-obstruction will be a useful supplemental therapy, decreasing the diameter of the intestinal lumen and enhancing resolution of ileus/pseudo-obstruction
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 100% Oxygen | To provide hospitalized ileus or pseudo-obstruction patient with 100% oxygen via non-rebreather face mask, for 6 hours |
Timeline
- Start date
- 2018-01-25
- Primary completion
- 2019-10-17
- Completion
- 2019-10-17
- First posted
- 2017-12-29
- Last updated
- 2019-12-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03386136. Inclusion in this directory is not an endorsement.